Results 221 to 230 of about 37,818 (285)

Perspective: Depression in Persons with Parkinson's Disease

Movement Disorders, EarlyView.
Abstract Depression is a prevalent and disabling syndrome characterized by sustained sadness and/or anhedonia, as well as cognitive and physical symptoms. In Parkinson's disease (PD), depression is both common and clinically challenging due to overlapping symptoms and complex etiologic interactions. Major depressive disorder occurs in approximately 17%
Albert F.G. Leentjens, Gregory M. Pontone   +1 more
wiley   +1 more source

Novelties in the pragmatic management of anaphylaxis in pediatric age. [PDF]

Eur J Pediatr
Marseglia GL, Tosca MA, Miraglia Del Giudice M, Manti S, Ciprandi G, Licari A.   +5 more
europepmc   +1 more source

Revisiting the Association Between Calcium Channel Blockers and Parkinson's Disease in the E3N Cohort

Movement Disorders, EarlyView.
Abstract Background Previous studies on calcium channel blockers (CCBs) and Parkinson's disease (PD) risk reached conflicting conclusions. Objectives We examined the relationship between CCBs and PD in the E3N cohort of French women followed for 15 years (2004–2018), while taking into account the potential for reverse causation.
Emilie Moutard, Agnès Fournier, Émeline Courtois, Fanny Artaud, Pascale Tubert‐Bitter, Emmanuel Roze, Ismaïl Ahmed, Anne C.M. Thiébaut, Alexis Elbaz, Thi Thu Ha Nguyen   +9 more
wiley   +1 more source

Quantification of 10B and 11B in Biological Samples in Translational Science and Clinical Applications for Boron Neutron Capture Therapy (BNCT)

Medicinal Research Reviews, EarlyView.
ABSTRACT Boron neutron capture therapy (BNCT) is a targeted radiotherapy that exploits the selective accumulation of the 10B isotope within tumors, followed by irradiation with low‐energy neutrons to induce high linear energy transfer particles with short path lengths, resulting in localized tumor cell destruction while sparing surrounding healthy ...
Christoph Selg, Wolfgang A. G. Sauerwein, Evamarie Hey‐Hawkins   +2 more
wiley   +1 more source

[The opinion about the reimbursement mechanism for psychotropic drugs for mental disorders].

Psychiatria polska, 2004
openaire   +1 more source

Public procurement of cardiac implantable electronic devices across Europe: are we purchasing value or cost-effectiveness? [PDF]

Europace
Osoro L, Arbelo E, Kozhuharov N, Landen R, Martinek M, Leclerq C, Fauchier L, De Haro JC, Boveda S, Sommer P, Rienstra M, Symanski P, Farkowski M, Egorova A, Moscoso Costa F, Tint D, Simovic S, Dzhinsov K, Leyva F, Boriani G, Figueras J, Ihara Z, Merino JL, Burri H, Pürerfellner H, Casado-Arroyo R.   +25 more
europepmc   +1 more source

A Critical Evaluation of Contextual Factors Affecting the Implementation of Pharmacist-Led Colorectal Cancer Screening: A Scoping Narrative Hybrid Review. [PDF]

Prev Chronic Dis
Nkemdirim Okere A, Islam MM.
europepmc   +1 more source

Early and accelerated access programs for medical devices in the European Union: mapping regulatory derogations and national schemes. [PDF]

Front Med Technol
Haon B, Hartmann M, Akodad S, Stevens H, Rochaix L.   +4 more
europepmc   +1 more source